×
Bausch Health Cos Long Term Debt 2010-2024 | BHC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bausch Health Cos long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
View More
Bausch Health Cos Long Term Debt 2010-2024 | BHC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bausch Health Cos long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19.4B
Dr Reddy's Laboratories (RDY)
$11.2B
BridgeBio Pharma (BBIO)
$6.9B
Supernus Pharmaceuticals (SUPN)
$1.9B
Amphastar Pharmaceuticals (AMPH)
$1.5B
Personalis (PSNL)
$412M
Taysha Gene Therapies (TSHA)
$336M
Assembly Biosciences (ASMB)
$81M
Sol-Gel Technologies (SLGL)
$16M
Evoke Pharma (EVOK)
$8M
Teligent (TLGT)
$0M